Justin Thacker serves as Executive at Design Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Justin Thacker has executed 1 insider transactions totaling $350.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 30, 2021 involved purchasing 17,500 shares valued at $350.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 30, 2021 | DSGN | $350.0K | Purchase | 17,500 | $20.00 | Discretionary |
Justin Thacker currently holds 17,500 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Justin Thacker has been a net buyer of DSGN stock. They have purchased $350.0K and sold $0 worth of shares.
Justin Thacker's most recent insider trade was on Mar 30, 2021, when they purchased 17,500 shares at $20.00 per share.
Get notified when new Form 4 filings are submitted